What is the standard starting dose for Humilin M3 (human insulin) in units?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 5, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

From the Guidelines

The standard starting dose for Humulin M3 is typically 10 units per day or 0.1–0.2 units/kg/day, depending on the degree of hyperglycemia, as recommended by the most recent guidelines 1.

Key Considerations for Insulin Therapy

  • Humulin M3 is a premixed insulin containing 30% soluble insulin (regular) and 70% isophane insulin (NPH), designed to provide both immediate and intermediate-acting coverage.
  • The dose should be administered subcutaneously 30 minutes before meals, usually breakfast and dinner.
  • Insulin requirements vary significantly between individuals based on factors such as weight, insulin sensitivity, carbohydrate intake, physical activity level, and concurrent medications.

Adjusting the Dose

  • Blood glucose monitoring is essential when starting insulin therapy, and the dose should be adjusted gradually based on pre-meal and bedtime glucose readings.
  • Hypoglycemia is the most common side effect of insulin therapy, so patients should be educated about recognizing and treating low blood sugar episodes.
  • The initial dose is intentionally conservative to minimize this risk, with the expectation that upward adjustments will likely be needed over time, as supported by recent studies 2, 1.

Important Factors to Consider

  • The progressive nature of type 2 diabetes should be regularly and objectively explained to patients, and insulin therapy should not be delayed in patients not achieving glycemic goals 2.
  • Equipping patients with an algorithm for self-titration of insulin doses based on self-monitoring of blood glucose improves glycemic control in patients with type 2 diabetes initiating insulin 2.
  • Comprehensive education regarding self-monitoring of blood glucose, diet, and the avoidance of and appropriate treatment of hypoglycemia are critically important in any patient using insulin 2, 1.

From the Research

Standard Starting Dose for Humilin M3

The standard starting dose for Humilin M3 is not explicitly stated in the provided studies. However, some information can be gathered from the following points:

  • In the study 3, seven normal volunteers received 20 IU of each insulin subcutaneously, including Humulin M3, in a randomized fashion on separate days.
  • There is no direct information on the standard starting dose for Humilin M3 in the other studies 4, 5, 6, 7. Some key points to consider:
  • The study 3 used 20 IU of Humulin M3, but it does not specify this as a standard starting dose.
  • The other studies do not provide information on the standard starting dose for Humilin M3. Key findings:
  • The dose of 20 IU of Humulin M3 was used in a study comparing the pharmacokinetics and metabolic effects of human regular and NPH insulin mixtures 3.
  • No other studies provided information on the standard starting dose for Humilin M3.

References

Related Questions

For a 59-year-old, 123‑kg man with type 2 diabetes (creatinine 0.84 mg/dL, eGFR > 90 mL/min) currently on U‑500 regular insulin (115 U at breakfast, 115 U at lunch, 50 U at dinner) and receiving dexamethasone 10 mg at 16:00 and 6 mg at 14:30, what NPH (intermediate‑acting) insulin dose should be added and how should the U‑500 insulin doses be adjusted?
In a 59-year-old male weighing 123 kg with type 2 diabetes and normal renal function (creatinine 0.84 mg/dL, eGFR >90 mL/min) who is on U‑500 insulin (115 U at breakfast, 115 U at lunch, 50 U at dinner) and received dexamethasone 10 mg at 16:00, what should the U‑500 dinner insulin dose be adjusted to?
In a 59-year-old man with type 2 diabetes weighing 123 kg who is currently receiving U‑500 regular insulin (115 units at breakfast, 115 units at lunch, 50 units at dinner) and dexamethasone (10 mg administered 40 hours ago, 6 mg administered 16 hours ago, another 6 mg scheduled at 14:00 today), with recent capillary glucose values of 362 mg/dL at breakfast, 270 mg/dL at lunch, 217 mg/dL at dinner, 261 mg/dL at 22:00, and 201 mg/dL at 02:00 despite correction doses, what should the U‑500 insulin doses be for breakfast, lunch, and dinner today?
In a 59‑year‑old man with type 2 diabetes, weight 123 kg, on U‑500 regular insulin (115 U breakfast, 115 U lunch, 50 U dinner) who received dexamethasone 10 mg 40 hours ago, dexamethasone 6 mg 16 hours ago, and will receive another 6 mg at 14:00 today, with capillary glucose consistently >200 mg/dL despite correctional short‑acting insulin, how should his insulin regimen be adjusted?
For a 59‑year‑old male weighing 123 kg with type 2 diabetes and normal renal function, who is currently on U‑500 regular insulin (115 U before breakfast, 115 U before lunch, 50 U before dinner) and receiving dexamethasone 10 mg at 16:00 today and 6 mg at 14:30 tomorrow, what initial NPH insulin dose should be added and how should the U‑500 regular insulin doses be adjusted?
What is the recommended duration of antifungal treatment after abdominal surgery?
Does dialysis worsen Hepatorenal Syndrome (HRS)?
What is ectopy?
Is Tylenol (acetaminophen) safe to use during breastfeeding?
When can a woman take a bath postpartum after a 3rd degree (third degree) perineal tear?
Is Dr. Barbara O'Neil's Gava Spuralina with apple cider vinegar effective in reducing Type 2 Diabetes Mellitus (T2DM)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.